Clinical trial
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
NCT00006398 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00006398 |
|---|---|
| Title | Prevention of Esophageal Varices by Beta-Adrenergic Blockers |
| Official title | Randomized, Double-Blind Study of Timolol (A Nonselective Beta-Adrenergic Blocker) vs Placebo to Prevent Complications of Hepatic Portal Hypertension in Patients With Cirrhosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Yale University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophageal and Gastric Varices, Liver Cirrhosis, Portal Hypertension |
| Intervention type | Drug |
| Interventions | Timolol Maleate, Placebo |
| Enrollment | 213 |
| Start date | Aug 1, 1993 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Oct 6, 2000 |
| Last update posted | Jun 1, 2017 |
| Countries | Spain, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: